Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experience

Ahmed Ayuna; Sherif Seif; John MacDonald; Ayyaz Sultan

doi:10.1016/j.ihj.2021.03.011

Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experience

Indian Heart J. 2021 May-Jun;73(3):385-386. doi: 10.1016/j.ihj.2021.03.011. Epub 2021 Mar 27.

Authors

Ahmed Ayuna¹, Sherif Seif², John MacDonald³, Ayyaz Sultan⁴

Affiliations

¹ Cardiology Registrar with Interest in Interventional Cardiology, Salford Royal NHS Foundation Trust, Manchester, UK. Electronic address: [email protected].
² Cardiology Clinical Fellow, Royal Albert Edward Infirmary, WWL NHS Trust, Wigan, UK.
³ FRCP Consultant Cardiologist Salford Royal NHS Foundation Trust, Manchester, UK.
⁴ FRCP Consultant Cardiologist Royal Albert Edward Infirmary, WWL NHS Trust, Wigan, UK.

Abstract

A single-centre retrospective observational study aimed at observing the outcomes of using DEB in ACS patients. All-comer ninety patients were included with a follow-up of 12-36 months. DEBs were deployed successfully yielding TIMI 3 without significant coronary dissection. MACE was 1.1% and 3.3% for 30 days and 12-36 months respectively.

Keywords: Acute coronary syndrome; Coronary artery disease; Drug-eluting balloon; Paclitaxel coated balloon; de-novo vessel disease.

Publication types

Observational Study

MeSH terms

Acute Coronary Syndrome* / diagnosis
Acute Coronary Syndrome* / therapy
Angioplasty, Balloon, Coronary
Cardiovascular Agents
Coronary Angiography
Coronary Artery Disease / diagnosis
Drug-Eluting Stents*
Humans
Paclitaxel
Pharmaceutical Preparations
Treatment Outcome

Substances

Cardiovascular Agents
Pharmaceutical Preparations
Paclitaxel